Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy ADMA Biologics stock | $1.1

Learn how to easily invest in ADMA Biologics stock.

ADMA Biologics Inc is a biotechnology business based in the US. ADMA Biologics shares (ADMA) are listed on the NASDAQ and all prices are listed in US Dollars. ADMA Biologics employs 406 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in ADMA Biologics

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ADMA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

ADMA Biologics stock price (NASDAQ: ADMA)

Use our graph to track the performance of ADMA stocks over time.

ADMA Biologics shares at a glance

Information last updated 2021-10-09.
Latest market close$1.10
52-week range$1.11 - $3.11
50-day moving average $1.24
200-day moving average $1.57
Wall St. target price$6.60
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.69

Buy ADMA Biologics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy ADMA Biologics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ADMA Biologics price performance over time

Historical closes compared with the close of $1.1 from 2021-10-15

1 week (2021-10-06) -1.79%
1 month (2021-09-16) -8.33%
3 months (2021-07-16) -28.10%
6 months (2021-04-16) -33.33%
1 year (2020-10-16) -51.54%
2 years (2019-10-16) -74.65%
3 years (2018-10-16) 5.29
5 years (2016-10-14) 6.39

ADMA Biologics financials

Revenue TTM $58.1 million
Gross profit TTM $-11,571,643
Return on assets TTM -15.75%
Return on equity TTM -78.11%
Profit margin -126.67%
Book value $0.85
Market capitalisation $148.7 million

TTM: trailing 12 months

Shorting ADMA Biologics shares

There are currently 11.6 million ADMA Biologics shares held short by investors – that's known as ADMA Biologics's "short interest". This figure is 5.1% down from 12.2 million last month.

There are a few different ways that this level of interest in shorting ADMA Biologics shares can be evaluated.

ADMA Biologics's "short interest ratio" (SIR)

ADMA Biologics's "short interest ratio" (SIR) is the quantity of ADMA Biologics shares currently shorted divided by the average quantity of ADMA Biologics shares traded daily (recently around 5.8 million). ADMA Biologics's SIR currently stands at 2. In other words for every 100,000 ADMA Biologics shares traded daily on the market, roughly 2000 shares are currently held short.

However ADMA Biologics's short interest can also be evaluated against the total number of ADMA Biologics shares, or, against the total number of tradable ADMA Biologics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ADMA Biologics's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 ADMA Biologics shares in existence, roughly 90 shares are currently held short) or 0.0986% of the tradable shares (for every 100,000 tradable ADMA Biologics shares, roughly 99 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ADMA Biologics.

Find out more about how you can short ADMA Biologics stock.

ADMA Biologics share dividends

We're not expecting ADMA Biologics to pay a dividend over the next 12 months.

ADMA Biologics share price volatility

Over the last 12 months, ADMA Biologics's shares have ranged in value from as little as $1.11 up to $3.111. A popular way to gauge a stock's volatility is its "beta".

ADMA.US volatility(beta: 1.26)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ADMA Biologics's is 1.2577. This would suggest that ADMA Biologics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

ADMA Biologics overview

ADMA Biologics, Inc. , a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers.

Frequently asked questions

What percentage of ADMA Biologics is owned by insiders or institutions?
Currently 3.83% of ADMA Biologics shares are held by insiders and 36.21% by institutions.
How many people work for ADMA Biologics?
Latest data suggests 406 work at ADMA Biologics.
When does the fiscal year end for ADMA Biologics?
ADMA Biologics's fiscal year ends in December.
Where is ADMA Biologics based?
ADMA Biologics's address is: 465 State Route 17, Ramsey, NJ, United States, 07446
What is ADMA Biologics's ISIN number?
ADMA Biologics's international securities identification number is: US0008991046
What is ADMA Biologics's CUSIP number?
ADMA Biologics's Committee on Uniform Securities Identification Procedures number is: 000899104

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site